Objective-In congestive heart failure (CHF) the skeletal muscle of the lower limbs develops a myopathy with atrophy and shift from the slow type to the fast type fibres. 
15.2)% in CHF, 59.5 (1.0)% in disuse atrophy and 60-3 (1.4)% in controls (P < 0 001 v both). The degree of muscle atrophy as calculated by the body mass index/gastrocnemius cross sectional area, showed a profound degree of atrophy in patients with muscle disuse [0.94 (0.39)]. This was worse than in the controls [4.27 (0.16) [23.5 (7.4) v 7'25 (7.92), P < 0.001]. There was a similar trend for MHC2a (15.01) v 8 25 (9.12), P < 0.05]. Within the CHF group there was a positive correlation between NYHA class and MHC2a (r = 0-47, P < 0.05) and MHC2b (r = 0-55, P < 0.01) and a negative correlation between NYHA class and MHC1 (r = -0-74, P < 0.001).
Similarly, significant correlations were found for ejection fraction, diuretic consumption score, exercise test tolerance, and degree of muscle atrophy. Conclusions-The CHF myopathy appears to be specific and not related to detraining. The magnitude of MCH redistribution correlates with the severity of the disease. The electrophoretic micromethod used is very sensitive and reproducible. Biopsies are so well tolerated that can be repeated frequently, allowing thorough follow up.
(Heart 1996;76:337-343) Keywords: congestive heart failure; skeletal muscle myopathy; myosin heavy chains; microbiopsies In congestive heart failure (CHF) lower limb skeletal muscle performance is disordered and this can at least in part explain symptoms such as fatigue and shortness of breath.' Lipkin et 
Methods

PATIENTS
Nineteen patients with CHF (10 males, nine females) (nine with dilated cardiomyopathy, four with hypertensive heart disease, and six with ischaemic heart disease) were studied. These were all patients whose diagnosis was established by means of clinical history, ECG, exercise test, echocardiography, and coronary angiogram. We also studied five patients (three males, two females) with disuse atrophy who had been restricted in bed for more that one year because of stroke and in whom a rehabilitation programme was unsuccessful. These all were normotensive (BP < 140/95 mm Hg), had normal cardiac function (ejection fraction ) 60%), and had no cross sectional echocardiographic and echo-Doppler cardiac abnormalities. Seven healthy volunteers (four males, three females) with normal medical history, physical examination, normal blood pressure values, ECG, echocardiography, and exercise test tolerance were used as controls. In all the patients the presence of major blood flow abnormalities in the lower limbs was excluded by a Winsor (ankle/brachial) index of > 1. SKELETAL We used the gastrocnemius cross sectional area to body mass index (BMI) ratio to assess the degree of muscle atrophy. Cross sectional area was measured with a computerised tomography scan. Transverse images were obtained in the same location on each leg one third distal to the popliteal space.
ELECTROPHORETIC SEPARATION OF MHC
The method is an improvement of that developed by Carraro et al.1 Biopsies were solubilised in 100-200 jA of 2-3% sodium dodecyl sulphate (SDS), 10% glycerol, 0 5% 2-mercaptoethanol, and 62-5 mM Tris-HCl pH 6-8 and boiled for five min. The running buffer was added to the sample in a ratio of 1:1 vol/vol. Analytical SDS page of MHC was performed on 7% polyacrylamide slabs, prepared according to Laemmli,"2 but 37-5% vol/vol glycerol was present in both the separating and the stacking gel. The stacking gel was composed of 37-5% glycerol, 4% T acrylamide-Bis (36X5:1), 12X5 mM Tris-HCl (pH 6 8), and 0-1% SDS. The separating gel was composed of 37-5% glycerol, 7% T acrylamide-Bis (36-5:1), 375 mM Tris-HCl (pH 8 8), and 0I1% SDS. Running buffer was made of 50 mM Tris, 384 mM glycine, pH 8-3, and 0'2% SDS. Separation of MHC was achieved using constant current at 4 mA (corresponding to about 40 V). After 6-8 h the running buffer was changed and electrophoresis restarted with the same parameters. After 24 h the voltage rises to about 130-160 V and the run is stopped." Gels containing approximately 0-2 jug of protein per band are usually stained with 0-1% Coomassie brilliant blue in 5% acetic acid/40% methanol and destained with 40% methanol/7% acetic acid. Some gels with less than 0-1 jIg protein loaded were afterward stained with the silver method. 
Results
AGE
Age did not differ significantly in the three groups of patients, being 71 2 (7-6) years in the CHF group, 71-0 (81) in the disuse atrophy patients, and 55-4 (8&5) in the control subjects.
NYHA CLASS
Of the CHF patients, four were in NYHA class I, four in class II, eight in class III, and three in class IV.
ECHOCARDIOGRAPHIC INDICES
Ejection fraction was 42-5 (15-2)% (n = 17) in CHF patients. This was significantly lower (P < 0 001) than in either disuse atrophy or control subjects [59-5 (1-0), n = 5, and 6053 (1-4), n = 7, respectively]. There were no significant differences between the two latter groups, neither were there significant differences in LVESD between CHF, disuse atrophy, and control subjects [38&7 (13-5) mm, 29 0 (2-9) mm, and 32-0 (1<1) mm, respectively], although there was a trend in CHF patients for slightly higher values (P = 01). LVEDD values showed a similar trend, being 57-8 (11-8) mm in CHF, 54-1 (11.2) mm in disuse atrophy, and 55-1 (12-8) mm in controls. A/E ratio was significantly higher in the seven patients with CHF and sinus rhythm in whom it could be measured [1-06 (0531) atrophy patients showed a remarkable shift toward the slow isoforms. In fact the percentage of MHC1 was significantly higher [84-50 (17-04)] than that of CHF patients (P < 0-01) and showed a trend toward significance when compared to that of control patients (P < 0d1) (fig 2) . On the other hand there was a decrease in both the percentage of MHC2a [8&25 (9-12)] and MHC2b [7-25 (7 92)]. The percentage of the fast oxidative fibres was significantly smaller than in the CHF patients and controls (P < 0 05 for both) (fig 3) . The fast glycolytic myosin percentage was significantly lower than in the CHF patients (P < 0-001) (fig 4) .
CORRELATION BETWEEN MHC COMPOSITION AND CLINICAL SEVERITY OF CHF
Clinical indices of the severity of heart failure were correlated with MHC composition in patients with CHF and controls. Figure 4 Myosin heavy chain 2b (MHC2b) composition in congestive heartfailure (CHF), control subjects, and disuse atrophy patients. aa P < 0 01; bb P < 0 001; cc P = NS. MHC1 (r = 0-65, P < 0-001) and negatively with MHC2a (r = -0 75, P < 0.001).
Although there was a trend for MHC2b to decrease in patients with higher ejection fraction, this did not reach statistical significance ( r = 0-26,P = NS) (fig6). CSA/BMI 4 5 Diuretic consumption Diuretic consumption score correlated negatively with MHC 1 (r = -0*62, P < 0O00 1) and positively with MHC2a (r = 0-35, P < 0.1) and MHC 2b (r = 0-49, P < 0-001) (fig 7) .
Exercise test tolerance
There were significant correlations between steps reached on the treadmill and MHC composition. The correlation was positive for MHC1 (r = 0-65, P < 0-001) and negative for MHC2a (r = -0 37, P < 0 05) and MHC 2b (r = -0-57, P < 0-01) (fig 8) .
LVESD and LVEDD There was no significant correlation between MHC composition and either LVEDD or LVESD, although there was a trend for LVESD to correlate negatively with MHC 1.
Degree of muscle atrophy Combining the data from CHF and control subjects, there was a significant positive correlation between the BMI/CSA ratio index and MHC1 (r = 0 44, P < 0 05). MHC2b was negatively correlated with BMI/CSA (r = -0 49, P < 0 05). There was no correlation with MHC2a (r = 010, P = NS) (fig 9) .
REPRODUCIBILITY OF THE METHOD
Five biopsies were taken from the same subject with CHF and processed separately. Samples from the five different biopsies were loaded on the same slab gel. The coefficient of variation between the five samples was 5% for MHC1, 5% for MHC2a, and 7% for MHC2b. We also loaded on five separate SDS-page samples from one patient. Electrophoreses were carried out on separate days, and the sample-once solubilised in SDS, 2-mercaptoethanol, and TrisHCl-was kept in a fridge at -10°C until the next experiment was done. Our data do not entirely support the hypothesis that prolonged immobilisation is the cause of changes in MHC composition of skeletal muscle. In fact our patients with disuse atrophy, though there were only five, showed a shift toward the slow MHC1 myosin and thus their behaviour was opposite to CHF patients. On the other hand the degree of muscle atrophy within the control and CHF patients correlated with the progressive decrease in MHC1 and group.bmj.com on June 27, 2017 -Published by http://heart.bmj.com/ Downloaded from increase of MHC2b content. We also found a correlation between MHC composition and indicators of severity of CHF such as NYHA class, exercise tolerance, diuretic consumption, and ejection fraction. It seems that patients with CHF have a specific myopathy, the severity of which is related to that of the heart failure syndrome. It may well be that in these patients the correlation between degree of atrophy and MHC composition is simply the reflection of two phenomena heading in the same direction:
(1) progressive muscle deconditioning, which in turn leads to muscle wasting and atrophy without changes in fibre distribution,89 and (2) intrinsic changes in skeletal muscle leading to a shift in the contractile protein pattern. This second phenomenon could resemble what occurs in the heart, where adaptive changes in the isozymic composition of the myocardium are observed during the development of both hypertrophy and failure.2425
The existence of a specific skeletal muscle myopathy with selective type I fibres atrophy has been reported already by Caforio et al26 in patients with cardiomyopathies. Changes in skeletal muscle in CHF are very much the same of those observed in the muscle denervation in the rat, where an increased expression of adult fast myosins occurs.27 Since the synthesis of adult slow myosins is dependent on the activity of motor innervation, while adult fast myosin is expressed in denervated fibres even though the neuronal influences are removed,2829 we cannot exclude a neural contribution to the origin of the myopathy. Coats et al have recently proposed the "ergo-and metabolo-receptors" theory to explain symptoms and muscle wasting in CHF.30 Chemically sensitive receptors detect muscle work and metabolism and transmit to the central nervous system stimuli that can drive blood pressure responses and increase sympathetic activity. An increased ergoreceptor activity in patients with CHF might maintain the increased sympathetic outflow, with consequent increased peripheral resistances, decreased perfusion, and further muscle deterioration. Alternatively circulating factors such as increased concentrations of tumour necrosis factor31 or metabolic and vascular alterations like insulin resistance32 or increased thickness of the endothelial cells33 can be invoked as determinants of muscle changes.
The novelty of our study is the application to very small biopsies, and for the first time in cardiology, of a high resolution micromethod that allows separation of the three MHCs isoforms from extremely small tissue samples. The reproducibility of this method is fairly high. Fine needle biopsies are extremely easy to perform and so well tolerated that they do not require any sort of anaesthesia. We had no complications in our series of patients. The 
